Menu
We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our unique, behaviour based zebrafish screening technology.
| Indication | Product | Drug discovery | Preclinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|
| ADHD | 3Z-20-001 | |||||
| ADHD | 3Z-20-002 | |||||
| ADHD | 3Z-20-003 | |||||
| ADHD | 3Z-20-004 | |||||
| Insomnia | 3Z-20-004 |